Skip to main content

FDA declines dapagliflozin indication as adjunct for type 1 diabetes

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA declines dapagliflozin indication as adjunct for type 1 diabetes

User login

Username

Password

Reset your password

Type	Lead	score